Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BPL-1357 Against H1N1 Influenza Virus Challenge
NCT07215858Phase 2Recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2026
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
A Phase 2 trial of BPL-1357 in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2026; status: recruiting.
02
Drugs
BPL-1357
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07215858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07215858.